My HPRA: Register

IRBESARTAN HCT ZENTIVA

300/12.5 Milligram Tablets

Sanofi aventisEU/1/06/377/6-10,17-22

Main Information

Trade NameIRBESARTAN HCT ZENTIVA
Active SubstancesIRBESARTAN
HYDROCHLOROTHIAZIDE
Strength300/12.5 Milligram
Dosage FormTablets
Licence HolderSanofi aventis
Licence NumberEU/1/06/377/6-10,17-22

Group Information

ATC CodeC09DA04 Angiotensin II antagonists and diuretics

Status

Authorised/WithdrawnAuthorised
Licence Issued19/01/2007
Supply StatusSupply through pharmacies only
Dispensing StatusProduct subject to prescription which may be renewed (B)
Marketing Status--Unknown--
Promotion StatusPromotion to Healthcare Professionals only
Conditions of Licence

Documents

Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back
Follow medicine

Print